Study links age, insurance, but not race, to chemo rates
(HealthDay) -- For women with breast cancer, disease characteristics correlate significantly with chemotherapy receipt, with no indication of racial barriers to treatment, according to a study published online ...
Cancer
Aug 10, 2012 |
not rated yet |
0
Heart failure in older breast cancer patients linked to medication
Heart failure is a relatively common complication in older women with breast cancer, but the risk is even higher in those patients treated with adjuvant trastuzumab (Herceptin), Yale School of Medicine researchers report ...
Cardiology
Nov 14, 2012 |
not rated yet |
0
|
Bevacizumab doesn't prolong survival in stage II-III colon CA
(HealthDay)—For patients with stage 2 to 3 colon cancer, the addition of bevacizumab to modified fluorouracil, leucovorin, and oxaliplatin (FOLFOX6) does not prolong disease-free or overall survival, according ...
Cancer
Dec 12, 2012 |
not rated yet |
0
Researcher shows diabetes, blood pressure link to colon cancer recurrence, survival
By all accounts, a combination of colon cancer, diabetes and high blood pressure can be a recipe for medical disaster. Now, a new study led by a surgical oncologist and researcher at Temple University School of Medicine and ...
Cancer
Dec 20, 2012 |
not rated yet |
0
Therapy appears to reduce rate of chemotherapy-induced early menopause for women with breast cancer
Temporarily suppressing ovarian function with use of the hormone analogue triptorelin reduced the occurrence of early menopause induced by chemotherapy among women with breast cancer, according to a study in the July 20 issue ...
Cancer
Jul 19, 2011 |
not rated yet |
0
Prospective study finds many children with retinoblastoma can safely forego adjuvant chemotherapy
New results from a prospective clinical trial conducted in France show that children with low-risk retinoblastoma do not need postoperative (adjuvant) chemotherapy to prevent disease recurrence or metastasis; the results ...
Cancer
Mar 04, 2013 |
not rated yet |
0
Epigenetic changes play a key role in development of chemo resistance in BCa
At the 28th Annual EAU Congress currently ongoing in Milan until Tuesday, W. Tan and colleagues presented their study on neoadjuvant cisplatin-based chemotherapy which showed that epigenetic changes are potential key drivers ...
Cancer
Mar 18, 2013 |
not rated yet |
0
Complementary meds used by 17 percent of elderly with cancer
(HealthDay) -- The prevalence of older people with cancer using complementary medications as they start a chemotherapy regimen is 17 percent, and is associated with less advanced disease and higher functional ...
Cancer
Mar 02, 2012 |
not rated yet |
0
Chemo-Linked factors may impact weight in breast cancer
(HealthDay) -- Adjuvant chemotherapy for early-stage breast cancer can induce weight gain and a variety of metabolic changes that may be associated with a poor prognosis for some patients, according to research ...
Cancer
Mar 29, 2012 |
5 / 5 (1) |
0
Chemo may extend survival after breast cancer's return
(HealthDay)—In women with breast cancer that has recurred but remains confined to in or near the breast, post-surgical chemotherapy appears to boost survival, new research shows.
Cancer
Dec 06, 2012 |
not rated yet |
0
Obesity linked to worse outcomes in early breast cancer treatment
Obesity is associated with worse outcomes overall in early-stage breast cancer, researchers reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011.
Cancer
Dec 08, 2011 |
not rated yet |
0
